Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer

BACKGROUND: As cancer treatment, biotherapies can be as effective as chemotherapy while reducing the risk of secondary effects, so that they can be taken over longer periods than conventional chemotherapy. Thus, some trials aimed at assessing the benefit of maintaining biotherapies during chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Guilloteau, Adrien, Abrahamowicz, Michal, Boussari, Olayide, Jooste, Valérie, Aparicio, Thomas, Quantin, Catherine, Le Malicot, Karine, Binquet, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796644/
https://www.ncbi.nlm.nih.gov/pubmed/33422006
http://dx.doi.org/10.1186/s12874-020-01202-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796644/
https://www.ncbi.nlm.nih.gov/pubmed/33422006
http://dx.doi.org/10.1186/s12874-020-01202-9

Ejemplares similares